TABLE 1.
Clinicopathological characteristics of patients included in this study (GSE13507).
| Variables | Value |
| Total patients | 164 |
| Male, n (%) | 134 (81.7) |
| Age, n (%) | |
| >65 year | 90 (54.9) |
| ≤65 year | 74 (45.1) |
| Muscle invasiveness, n (%) | |
| Non-muscle invasive | 103 (62.8) |
| Muscle invasive | 61 (37.2) |
| Grade, n (%) | |
| High grade | 59 (36.0) |
| Low grade | 105 (64.0) |
| Progression, n (%) | 30 (18.3) |
| Tumor stage, n (%) | |
| Ta | 24 (14.6) |
| T1 | 80 (48.8) |
| T2 | 31 (18.9) |
| T3 | 18 (11.0) |
| T4 | 11 (6.7) |
| Regional lymph node metastasis, n (%) | |
| N0 | 151 (92.1) |
| N1–3 | 13 (7.9) |
| Distant metastasis, n (%) | |
| M0 | 157 (95.7) |
| M1 | 7 (4.3) |